Abstract

AbstractThe effects of the aquaculture chemotherapeutant Salmosan® (active ingredient [a.i.]: azamethiphos) were examined in Pacific spot prawns (Pandalus platyceros) at three temperatures (5, 11, and 17°C). Post‐molt prawns were more sensitive to Salmosan® than intermolt prawns; repeated (3x) 1‐hr LC50 values for post‐molt prawns ranged from 17 (9.3–31 95% confident intervals) to 40 (25–63) μg/L a.i. while intermolt prawns survived 3 × 1‐hr exposures up to 100 μg/L a.i. Using LC50 values, Salmosan® was approximately 2.4 times more toxic at 17 versus 5°C. Temperature significantly altered chemosensory and locomotory behaviors in intermolt prawns with the highest activity at the intermediate temperature. Significant decreases in antennule flicking (84 and 104% over controls) were seen at 17°C after 3 × 1‐hr pulse exposures to 50 and 100 μg/L a.i., respectively. Temperature, but not Salmosan®, affected molting success: at 17°C significantly lower survival was seen during ecdysis (60% of those at 5°C) and at 5°C, molt time was longer (41 ± 3 days) compared to 11°C (34 ± 4 days) or 17°C (21 ± 4 days). Life stage (molt status) and environmental parameters (temperature) alter the effects of Salmosan® to non‐target spot prawns.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call